These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31088640)

  • 1. Positive selection of type 2 diabetes genotypes - the glycaemic threshold hypothesis.
    Wise PH
    Med Hypotheses; 2019 Jun; 127():150-153. PubMed ID: 31088640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis.
    Corbett SJ; McMichael AJ; Prentice AM
    Am J Hum Biol; 2009; 21(5):587-98. PubMed ID: 19533615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population.
    Saber-Ayad M; Manzoor S; El Serafi A; Mahmoud I; Hammoudeh S; Rani A; Abusnana S; Sulaiman N
    Gene; 2019 Jan; 681():93-98. PubMed ID: 30273662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance: a genetic approach. Overview.
    Martínez Larrad MT; González Sánchez JL; Serrano Ríos M
    Nestle Nutr Workshop Ser Clin Perform Programme; 2002; 6():79-93; discussion 93-5. PubMed ID: 16969968
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
    Gastaldelli A
    Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes?
    Stannard SR; Johnson NA
    J Physiol; 2004 Feb; 554(Pt 3):595-607. PubMed ID: 14608009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
    Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
    Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is insulin resistance the principal cause of type 2 diabetes?
    Gerich JE
    Diabetes Obes Metab; 1999 Sep; 1(5):257-63. PubMed ID: 11225637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
    Wimalawansa SJ
    J Steroid Biochem Mol Biol; 2018 Jan; 175():177-189. PubMed ID: 27662816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
    Després JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.
    Cryer PE
    Diabetologia; 2002 Jul; 45(7):937-48. PubMed ID: 12136392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.
    Fox R
    Gynecol Endocrinol; 1999 Dec; 13(6):390-3. PubMed ID: 10685332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome: from inherited survival trait to a health care problem.
    Colagiuri S; Brand Miller JC
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():54-60. PubMed ID: 9288547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and type 2 diabetes: role of the adipocyte.
    McPherson R; Jones PH
    Curr Opin Lipidol; 2003 Dec; 14(6):549-53. PubMed ID: 14624130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.